In: Finance
The following information was extracted from the accounting records of Belle Mare Limited
Statement of Comprehensive Income for the year ended 31 December
2018 (R) |
2017 (R) |
||
Sales |
1 856 000 |
1 200 000 |
|
Cost of sales |
(1 280 000) |
(750 000) |
|
Gross profit |
576 000 |
450 000 |
|
Operating expenses |
(291 200) |
(212 000) |
|
Depreciation |
30 000 |
26 000 |
|
Other operating expenses |
261 200 |
186 000 |
|
Operating profit |
284 800 |
238 000 |
|
Interest on mortgage loan |
(24 000) |
(72 000) |
|
Profit before tax |
260 800 |
166 000 |
|
Income tax |
(90 240) |
(58 100) |
|
Profit after tax |
170 560 |
107 900 |
Statement of Financial Position as at 31 December
2018 (R) |
2017 (R) |
||
ASSETS |
|||
Non-current assets |
2 464 160 |
2 444 000 |
|
Property, plant & equipment |
2 464 160 |
2 444 000 |
|
Current assets |
356 000 |
336 000 |
|
Inventories( all Trading Inventory) |
120 000 |
250 000 |
|
Trade & other receivables |
40 000 |
64 000 |
|
Cash & cash equivalents |
196 000 |
22 000 |
|
2820 160 |
2780 000 |
2018 (R) |
2017 (R) |
||
EQUITY & LIABILITIES |
|||
Equity |
2 437 560 |
1 980 000 |
|
Ordinary share capital (issue at R10 each) |
2 180 000 |
1 760 000 |
|
Retained income |
257 560 |
220 000 |
|
Non-current liability (Mortgage loan at 12% p.a.) |
200 000 |
600 000 |
|
Current liabilities |
182 600 |
200 000 |
|
Trade & other payables |
98 000 |
138 000 |
|
South African Revenue Services (income tax) |
8 600 |
6 000 |
|
Shareholders for dividends |
76 000 |
56 000 |
|
2 820 160 |
2 780 000 |
Additional information
Required:
Study the information provided above by Belle Mare Ltd and prepare the Statement of Cash Flows (using the indirect method) for the year ended by December 2018
STATEMENT OF CASH FLOWS | ||
Cash flows from operating activities: | ||
Net income | R 1,70,560 | |
Adjustments to reconcile net income to net cash provided by operating activities: | ||
Depreciation expense | R 30,000 | |
Decrease in trade and other receivables | R 24,000 | |
Decrease in inventory | R 1,30,000 | |
Increase in SARS | R 2,600 | |
Decrease in trade and other payables | R -40,000 | R 1,46,600 |
Net cash provided by operating activities | R 3,17,160 | |
Cash flows from investing activities: | ||
Purchase of PPE [2464160-2444000+144000+30000] | R -1,94,160 | |
Sale of fixed assets | R 1,44,000 | |
Net cash used investing activities | R -50,160 | |
Cash flows from financing activities: | ||
Repayment of non-current liability | R -4,00,000 | |
Issue of ordinary shares | R 4,20,000 | |
Payment of cash dividends [56000+133000-76000] | R -1,13,000 | |
Net cash provided by financing activities | R -93,000 | |
Net increase in cash | R 1,74,000 | |
Beginning balance of cash & cash equivalents | R 22,000 | |
Ending balance of cash & cash equivalents | R 1,96,000 |